HIV / AIDS
EACS 2017: New European Guidelines Cover HIV, Hepatitis C, and Related Conditions
- Details
- Category: HIV Treatment
- Published on Thursday, 30 November 2017 00:00
Everyone with HIV and hepatitis C virus (HCV) coinfection should receive direct-acting antiviral therapy for hepatitis C and should receive the same treatment regimens for hepatitis C as people with HCV monoinfection, new European guidelines issued at the 16th European AIDS Conference recommend.
EACS 2017: Fostemsavir Controls Viral Load in Half of People with Highly Drug-Resistant HIV
- Details
- Category: HIV Treatment
- Published on Thursday, 30 November 2017 00:00
Fostemsavir, a new experimental attachment inhibitor, suppressed viral load in over half of participants with extensive drug resistance when added to a background regimen selected by resistance testing, Max Lataillade of ViiV Healthcare reported at the recent 16th European AIDS Conference in Milan.
EACS 2017: European Cure Review Concentrates on HIV Therapeutic Vaccines
- Details
- Category: Search for a Cure
- Published on Friday, 17 November 2017 00:00
A cure for HIV would almost inevitably have to involve a vaccine to improve the body’s natural ability to control HIV, speakers said at a recent seminar on European HIV cure research. The STEPS seminar, put on by the European AIDS Treatment Group (EATG) ahead of the European AIDS Conference in Milan in October, also heard that, in the words of EATG member and European Community Advisory Board chair Giulio Maria Corbelli, "Cure research reminds us of the importance of patient involvement from the very earliest phases of the development of treatment and prevention."
Coverage of IDWeek 2017
- Details
- Category: HIV Treatment
- Published on Thursday, 30 November 2017 00:00
HIVandHepatitis.com coverage of IDWeek 2017, held October 4-8, 2017, in San Diego.
- Long-Acting Monoclonal Antibody Effective Against Multidrug-Resistant HIV
- Single-Tablet Protease Inhibitor Regimen Maintains Viral Suppression for a Year
11/30/17
EACS 2017: Up to a Quarter of HIV-Negative Gay Men Attending 3 English Clinics Used PrEP in the Last Year
- Details
- Category: HIV Prevention
- Published on Tuesday, 14 November 2017 00:00
A prospective cohort study of gay men attending 3 clinics in southern England --56 Dean Street and Mortimer Market Centre in London and the Brighton & Hove SHAC (Sexual Health & Contraception) service -- have found that 23% of HIV-negative service users who responded to a follow-up questionnaire had used PrEP (pre-exposure prophylaxis) in the last year. These interim results from the AURAH2 study were presented recently at the 16th European AIDS Conference (EACS 2017) in Milan.
Many Americans Still Get HIV Diagnosis Years After Infection, CDC Says
- Details
- Category: HIV Testing & Diagnosis
- Published on Wednesday, 29 November 2017 00:00
Many people with HIV in the United States are still being diagnosed with HIV late, and therefore are not getting the full therapeutic and prevention benefits of starting antiretroviral therapy (ART) early, according to the latest Vital Signs report from the Centers for Disease Control and Prevention (CDC), released in advance of World AIDS Day.
Coverage of the 16th European AIDS Conference
- Details
- Category: HIV Treatment
- Published on Tuesday, 14 November 2017 00:00
HIVandHepatitis.com and NAM coverage of the 16th European AIDS Conference (EACS 2017), October 25-27 2017, in Milan.
More Articles...
- EACS 2017: HIV Diagnoses in English Gay Men Have Been Falling Since 2014
- EACS 2017: High HIV Incidence from Non-Primary Partners and Low PEP and PrEP Use Seen in PARTNER Study
- EACS 2017: Swiss Study Examines When Gay Men Decided to Stop Consistent Condom Use
- EACS 2017: Survey of Dating App Users Finds that PrEP Usage Has Not Increased in Europe in the Last Year
- EACS 2017: Boosted Protease Inhibitor + Lamivudine Effective for HIV Maintenance Treatment
Web Design and Development by